Last reviewed: June 23, 2026

Last updated: June 23, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Semaglutide—a glucagon-like peptide-1 (GLP-1) receptor agonist—has demonstrated an average weight loss of 10-15% body weight in clinical trials when combined with lifestyle changes. Many people wonder whether this medication suits their needs, what realistic outcomes look like, and whether personalized alternatives might work better for their unique biology.

How Semaglutide Works for Weight Loss

Semaglutide mimics a natural hormone that regulates hunger and blood sugar. When injected weekly, it signals your brain to feel fuller faster, reduces cravings, and slows stomach emptying—all mechanisms that support sustained calorie reduction without extreme hunger. This dual action on appetite and metabolism is why many patients experience steady, consistent weight loss over months of treatment.

The medication activates GLP-1 receptors throughout the body, particularly in areas controlling hunger signals and energy expenditure. Clinical data shows that users typically lose weight during the first month and continue losing through months 4–6 of consistent use. Results plateau when lifestyle factors stabilize, making diet and exercise adherence essential for long-term success.

Clinical Evidence: What Studies Show About Semaglutide Results

Major trials including STEP 1, STEP 2, and STEP 3 documented weight loss ranging from 5% to 18% of baseline body weight over 68 weeks, depending on dose and patient adherence. Participants also showed improvements in blood pressure, fasting blood glucose, and cardiovascular risk markers. These results established semaglutide as a clinically validated option for individuals with obesity or overweight status plus weight-related health conditions.

Responders and non-responders exist in every medication trial. Some patients lose 20%+ of body weight; others experience modest reductions or plateau early. Individual response depends on genetics, starting metabolic rate, adherence to injections, and lifestyle changes. This variability is precisely why genetic testing through PlexusDx's Precision Peptide Genetic Test can identify your peptide-pathway predispositions before committing to a single therapy.

Potential Side Effects and Safety Considerations

Common side effects include nausea, vomiting, diarrhea, and constipation—typically mild to moderate and often improving after the first 2–4 weeks as your body adjusts. Rare but serious risks include pancreatitis, gallbladder issues, and thyroid concerns; anyone with a personal or family history of medullary thyroid cancer should avoid GLP-1 therapy entirely. Muscle loss can occur with rapid weight loss, making strength training and adequate protein intake important protective measures.

Dehydration and electrolyte imbalances may develop if nausea reduces fluid intake, so consistent hydration is essential. Some patients report fatigue or low energy during initial weeks—a sign your body is adapting to lower calorie intake. If side effects persist or worsen beyond the first month, discussing dose adjustments or alternative peptide therapies with your PlexusDx provider ensures you find a tolerable option that matches your health profile.

Semaglutide vs. Personalized Peptide Therapy: Finding Your Best Option

While semaglutide is effective for many, not everyone responds optimally to GLP-1 receptor activation alone. PlexusDx offers compounded semaglutide injections starting at $149/mo through licensed 503A pharmacies, ensuring consistent quality and accessibility across all 50 states without insurance requirements. For patients who may benefit from dual-peptide action, PlexusDx's GLP-Squared Injection combines semaglutide and tirzepatide in a single formulation, activating both GLP-1 and GIP pathways for enhanced appetite suppression and metabolic effects.

The Precision Peptide Genetic Test ($99 add-on after your first month) maps 14 pathways and 49 peptides, analyzing key variants like GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313. This personalized approach identifies which peptide receptors your body responds to most effectively, allowing your provider to recommend semaglutide, tirzepatide, a dual compound, or microdose protocols tailored to your genetic predispositions rather than trial-and-error treatment.

Is Semaglutide Right for You? Key Questions to Ask

Semaglutide works best if you have a BMI ≥27 with weight-related health concerns (high blood pressure, type 2 diabetes, elevated cholesterol) or a BMI ≥30 regardless of other conditions. You should be willing to commit to weekly injections, tolerate possible nausea during the first month, and sustain dietary and exercise changes—because stopping the medication typically leads to weight regain. If you have a history of medullary thyroid cancer or multiple endocrine neoplasia syndrome type 2, semaglutide is contraindicated.

Consider genetic testing if you've tried weight loss medications before without success, if side effects stop you from adhering to treatment, or if you want confidence that your chosen therapy matches your peptide-pathway biology. PlexusDx's flat monthly pricing model—your dose may need to go up, but your price won't—removes financial barriers to finding the right medication and dose for your body.

Getting Started with Semaglutide Through PlexusDx

PlexusDx compounded semaglutide injections begin at $149/mo across all commitment tiers, with weekly self-injection at home after your initial telehealth consultation. Each vial lasts 4 weeks; your provider will guide dose escalation from 0.25 mg up to your therapeutic level based on tolerance and weight loss progress. HSA and FSA accounts cover PlexusDx medications, and no membership fees or insurance approval is required—making treatment accessible within weeks rather than months.

After your first month, you can add the Precision Peptide Genetic Test for $99 to unlock personalized insights about your peptide receptors and optimize your ongoing therapy. If semaglutide alone plateaus or side effects emerge, PlexusDx providers can pivot to tirzepatide, GLP-Squared combinations, or microdose protocols without disrupting your care. Consistency, transparency, and pharmacist-compounded quality ensure you're receiving reliable, regulated medication at predictable cost.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

How much weight can I expect to lose on semaglutide?

Clinical trials show average weight loss of 10–15% of baseline body weight over 68 weeks, though individual results range from 5% to 20%+ depending on genetics, starting weight, and adherence. PlexusDx's Precision Peptide Genetic Test can help predict your likely response by identifying your GLP-1 receptor sensitivity before starting therapy.

How long does it take to see results with semaglutide?

Most patients notice appetite suppression and reduced cravings within 2–4 weeks of starting; measurable weight loss typically appears by week 4–6. Peak results occur around month 3–4 when your dose reaches therapeutic levels and lifestyle habits solidify. Continued weight loss extends through months 4–6, after which results plateau unless additional interventions are added.

What is the cost of semaglutide at PlexusDx?

PlexusDx compounded semaglutide injections start at $149/mo with flat pricing across all commitment tiers—your dose may go up, but your monthly cost won't. No insurance is required, and HSA/FSA accounts are eligible. Add-on genetic testing costs $99 after your first month to personalize your therapy.

Is compounded semaglutide safe and regulated?

Yes. PlexusDx compounds all semaglutide through licensed 503A pharmacies that follow strict FDA oversight for sterility, strength, and purity. While compounded medications are not FDA-approved the same way brand products are, 503A compounding ensures consistent quality and pharmacist verification before every shipment.

What if semaglutide doesn't work for me or causes side effects?

PlexusDx offers personalized alternatives including oral semaglutide ($249/mo), tirzepatide ($249/mo injection, $279/mo oral), and GLP-Squared dual-compound therapies. Your Precision Peptide Genetic Test identifies which peptide pathways your body responds to best, allowing your provider to switch medications without starting from scratch.

Can I use semaglutide if I have diabetes or other health conditions?

Semaglutide is safe and even beneficial for people with type 2 diabetes, as it lowers blood glucose alongside promoting weight loss. However, avoid semaglutide if you have a personal or family history of medullary thyroid cancer, multiple endocrine neoplasia syndrome type 2, or severe pancreatitis. Always disclose your complete medical history to your PlexusDx provider before starting.

Related Reading

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.

Real prescribers. Published prices. No surprises.

Licensed providers in all 50 states. Online intake. No insurance, no membership required.

Start My Intake →

~60 seconds · $0 charged until your provider approves